I have noticed a few rerates do 10 baggers, usually from mcap of 10-30m and in this case i doubt we can do that in less than 3-4yrs as we are already at 500m. We do have immense promise and there is no reason why we shouldn’t triple and some over the next 12 months in my view. If we have 2 drugs in the clinic and 3 more on the books and a partnership for another that would mean we had a cap raise in the middle but i think management are being careful not to do that at a lower price than prev cap raise. My sentiment is that thats something they do above 25c.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |